AEM
Aliases: ฮ-ethylmescaline, ฮ-ethyl-3,4,5-trimethoxyphenethylamine
Categories
Summary
AEM is an extremely rare and poorly documented phenethylamine psychedelic first synthesized by Alexander Shulgin and described in PiHKAL as entry #1. Shulgin reported that doses exceeding 220 mg produced few to no psychoactive effects, classifying it as essentially inactive. The compound's inactivity discouraged Shulgin from synthesizing further alpha-position-extended mescaline analogues (such as alpha-propylmescaline or alpha-butylmescaline). Research in rodents suggests these extended homologues are non-hallucinogenic. Due to the complete lack of human psychoactive data and unknown safety profile, AEM should be considered an inactive research chemical with no established use case.
Dose Information
| ROA | Light | Common | Strong | Heavy |
|---|---|---|---|---|
| Oral | Unknown(inactive)mg | - | - | - |
Tolerance
Effects
- Dilated pupils
- Introspection
- No significant psychoactive effects reported
- Color enhancement
- Visual distortions